Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eisai Inc.
The study will consist of 2 parts: (1) a single dose in healthy adult volunteers, at doses up to 100 mg or the maximum dose that can be tolerated, (2) a single dose of 25 mg or lower in healthy elderly volunteers.
Age
30–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Inclusion:
Healthy males and females
Aged 30 to 55 years, inclusive (Cohorts 1 through 5); aged 65 to 85 years, inclusive (Cohort 6)
Body mass index (BMI) of 18 to 32kg/m\^2 at Screening
Exclusion
Females of child-bearing potential
Personal or family history of neurological abnormalities
Any clinical abnormality of the electrocardiogram (ECG)at Screening and check-in
